Navigation path

Headlines

20 July 2017

Commission launches public consultation on Health and Care in the Digital Single Market

The European Commission launches a public consultation today on how Europe should promote digital innovation in health and care, for the benefits of citizens and of health systems in Europe. This consultation will help us to identify how to empower citizens, medical professionals and researchers; to ensure a right for citizens to have an electronic health record that they can access from everywhere in the EU, to improve prevention, rapid response to pandemic threats, personalised treatments and care.


19 July 2017

Innovative Medicines Initiative – new calls out

The Innovative Medicines Initiative has launched two Calls for proposals open, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. The deadline for both calls is 24 October 2017, 17:00, Brussels time.


29 June 2017

Antimicrobial Resistance: Commission steps us the fight with new Action Plan

The Commission continues to scale up its fight against antimicrobial resistance (AMR), with the launch of a second European Action Plan.

The new Action Plan is based on a One Health approach and focusses on supporting Member States, particularly in establishing, implementing and monitoring their National Action Plans. It also brings together EU funds and instruments to promote innovation and research against AMR and strengthen the EU's leading role in global fora, notably within the international organisations and with major trade partners.


20 June 2017

Launch of the African Access Initiative

The Initiative along with a white paper on cancer burden and emerging crisis in Africa, was launched at BIO 2017 in San Diego. Through the European and Developing Countries Clinical Trials Partnership (EDCTP), the European Commission has been actively involved in sub-Saharan Africa. EDCTP's objective in that area is to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases.


1 June 2017

€20 million EU loan to develop new device to quickly identify pathogens causing meningitis and other infectious diseases

An EU loan of €20 million will support a Barcelona-based start-up to develop and commercialise a device capable of identifying within an hour a range of infectious pathogens, such as those contained in meningitis, respiratory or gastro-intestinal infections. This loan is signed under the InnovFin Infectious Diseases Finance Facility.


5 April 2017

Katholieke Universiteit Leuven (KU Leuven) and partners developing dual vaccine against yellow fever and rabies, supported by Horizon 2020

The RABYD-VAX consortium, led by KU Leuven, is developing a cheap and easy-to-produce vaccine against rabies AND yellow fever which allows a stable temperature during transport and storage and thus guarantees a better efficiency compared to the existing vaccines.


3 April 2017

EMA publishes framework and action plan for closer interaction with academia

In the context of the European medicines regulatory network, the European Medicines Agency (EMA) has developed a framework and an action plan to reinforce collaboration with the academic community.


23 March 2017

ICPerMed Action Plan for Personalised Medicine published

The International Consortium for Personalised Medicine (ICPerMed), comprising over 30 European and international members, have published a consensus Action Plan on the research and development actions needed to further advance personalised medicine.


22 March 2017

Ebola vaccine immune responses of results obtained in EBOVAC1

EU-funded H2020 IMI research project on Ebola vaccine, EBOVAC1, induced durable immune response 1-year after vaccination.


21 March 2017

EU support the fight against tuberculosis: Reversion of antibiotic resistance in Mycobacterium tuberculosis

The newly identified molecule SMARt-420 has shown effective results in clearance promotion of multidrug-resistance strains of Mycobacterium tuberculosis from the lungs of mice.

The work received support from the European Research Council, Marie Skłodowska-Curie actions research fellowship and the EU collaborative research grant MM4TB.


20 March 2017

Health National Contact Points Network (Health NCP Net Project)


13 March 2017

Estimating the risk of microcephaly following Zika virus infection

The Horizon 2020 project ZIKAlliance published a study in the Bulletin of the World Health Organization, estimating the risk of microcephaly in women infected with Zika virus during pregnancy.

The study found that the risk varies substantially across Brazil, and was affected by different factors, such as the geographical area.


24 February 2017

European Medicines Agency (EMA) workshop on Seventh Framework Programme (FP7) small-population research methods projects and regulatory application

Three FP7 projects, Asterix, IDeAl and InSPiRe, are funded by the EU to develop new methodology on design and analysis of small population clinical trials since 2013.


23 February 2017

Third conference of the International Rare Diseases Research Consortium (IRDiRC)

The 3rd IRDiRC Conference took place in Paris on 8-9 February 2017, welcoming around 300 participants from around the globe, including rare disease researchers, clinicians, funders, political decision makers, patient organisation representatives and pharmaceutical industry members. Five years have passed since the official launch of IRDiRC and considerable advances have been made in rare diseases research. Indeed, the goal set by IRDiRC of delivering 200 new therapies for rare diseases and means to diagnose most rare diseases by 2020 has been passed.


8 February 2017

Advanced therapy medicines: towards increased development and patient access

The European Medicines Agency (EMA) has published today a set of ideas to better support development and expand patients’ access to high quality, safe and effective advanced therapy medicinal products (ATMPs).


6 February 2017

€1 Million was awarded to Minicare HNL, the winner of the Horizon Prize 'Better use of antibiotics'

On 6 February 2017, Carlos Moedas, EU Commissioner for Research, Science and Innovation, awarded a €1 million Prize to Minicare HNL , for a finger prick test that can diagnose in less than ten minutes a bacterial infection and identify if a patient can be treated safely without antibiotics.


31 January 2017

International Conference on Poverty-related and Neglected Diseases

Directorate General Research and Innovation, research funders, academia and policy makers gather tomorrow to discuss the conclusions and recommendations of the study on Poverty-related and Neglected Diseases (PRND). The study aimed to evaluate the role of EU research on PRND in contributing to achieving universal health coverage and improving population health in low and middle–income countries.


23 January 2017

Study of volunteer blood donors in Martinique provides new information about Zika virus infection

A large study of volunteer blood donors has been performed in Martinique Island during the local Zika outbreak in 2016 by Pierre Gallian and collaborators. The research team is part of ZIKAlliance, a project funded by the European Union Horizon 2020 Research and Innovation Programme to better understand the clinical and fundamental aspects of infections by Zika virus.


19 January 2017

Coalition for Epidemic Preparedness Innovation launched at the WEF Annual Meeting 2017

Launched today at the World Economic Forum (WEF) Annual Meeting in Davos was of the Coalition of Epidemic Preparedness Innovation (CEPI) – a global non-profit public-private partnership founded by the Government of Norway, the Government of India, the Bill & Melinda Gates Foundation, the Wellcome Trust and the WEF. The European Commission will contribute to CEPI's overall objectives in the area of epidemic preparedness, which are in line with that of the European Commission, and plans to co-fund actions with CEPI, such as through the Innovative Medicines Initiative.


17 January 2017

European Medicines Agency – 2016 highlights for human medicines

EMA has published an overview of its key recommendations of 2016 in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines.


17 January 2017

EU launches personalised medicine projects to foster treatment of inflammatory disorders

EU-funded flagship projects, MultipleMS and SYSCID, receive EUR 15m each. These two projects focus on precision diagnostics and therapeutic targets in chronic inflammatory and autoimmune disorders as a major health care burden of industrialised societies. Chronic inflammatory diseases and autoimmunity constitute a group of incurable disorders of the immune system with a lifetime prevalence of over 10% in Europe.


10 January 2017

Launch of a joint trans-national call for pathway analysis across neurodegenerative diseases

On 9 January 2017, the EU Joint Programme – Neurodegenerative Disease Research (JPND) has launched a joint trans-national call for pathway analysis across neurodegenerative diseases.

The €23 million call responds to a need of targeted investment to better understand the fundamental links between different diseases. It is made available to applicants from 20 countries.


15 December 2016

Malaria, HIV vaccine achievable ‘in one or two decades’ – Dr Leonardo Santos Simão

Photo of the interviewee

We will see vaccines for malaria and HIV within the next one or two decades, predicts Dr Leonardo Santos Simão, the former health minister of Mozambique, who has been appointed High Representative South of the European & Developing Countries Clinical Trials Partnership (EDCTP), which aims to accelerate the development of new treatments, vaccines and diagnostic tools for diseases in sub-Saharan Africa.


9 December 2016

Public stakeholder consultation

Interim evaluation of Joint Undertakings operating under Horizon 2020. All citizens and organisations are welcome to contribute to this consultation. Contributions are particularly sought from researchers, industry, entrepreneurs, innovators and all types of organisations that have participated in Horizon 2020 and in calls for proposals published by the Joint Undertakings in particular.


7 December 2016

Workshop on adaptive pathways – discussion on development approach for medicines addressing unmet medical needs

The European Medicines Agency in collaboration with the European Commission is organising a workshop on 8 December 2016 to gather the views of stakeholders on the adaptive pathways approach for medicine development. The registration is now closed but you can follow a live broadcast of the workshop by clicking on the 'multimedia' tab on the event page.


6 December 2016

RTD co-organises GloPID-R Zika Virus Research Workshop

Diseases like Zika virus infection do not respect borders, so scientists across the globe must work together to fight them. To reinforce such collaboration, a group of international scientists and research funders held a workshop in São Paulo on 30 November – 2 December 2016.

The workshop allowed for active exchanges on how to better collaborate together to ensure high quality, harmonised research addressing many of the remaining research questions on Zika virus infection and its complications. Opportunities identified for further collaboration include the integration of different cohort studies for a better understanding of the clinical spectrum of Zika virus infection, the need for consensus on experimental protocols for studies on pathogenesis, or on extending external quality assurance for diagnostic tools. Concrete initiatives for collaboration were launched, such as on vector studies or between the clinical trial and preparedness networks. The importance of timely data sharing in the context of public health emergencies was emphasised throughout the workshop.

The workshop was organised in the context of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), and was hosted by the University of São Paulo.


6 December 2016

EU-funded project coordinator, Jennifer Zeitlin, receives the "Stars of Europe" Award

Jennifer Zeitlin, coordinator of EU-funded project EPICE, received yesterday the "Stars of Europe" Award. The EUR 4 mil project explored the use of evidence based practices for the care of very preterm infants in 19 regions from 11 EU Member States. Under the auspices of the French Ministry of National Education and Research, this award is given to coordinators of European research and innovation projects supported by a French structure. The distinctions are selected by a high-level jury closely looking at the quality of scientific production, the creation of value and jobs, the societal dimension, the 'open to the world' aspect and gender balance. The Stars are an encouragement addressed to all actors, academic or private, to participate to what is now Horizon 2020, the EU framework programme for research and innovation.


2 December 2016

TRANSCAN-2: Third Joint Transnational Call for Proposals (JTC 2016)

Launch of the Third Joint Transnational Call for Proposals (JTC 2016) on “Minimally and non-invasive methods for early detection and/or progression of cancer ”


1 December 2016

European Medicines Agency Workshop: "Measuring the impact of pharmacovigilance activities"

The European Medicines Agency (EMA) is organising a workshop to discuss methods to measure the impact of pharmacovigilance activities on patient safety. The event will be web-streamed from the EMA premises in London, from 13:00 UK time on 5 December to 17:00 UK time on 6 December 2016.

More information


30 November 2016

Registrations are now open for the 3rd IRDiRC Conference

The 3rd International Rare Diseases Research Consortium (IRDiRC) Conference gathers stakeholders from around the world to share their experience, knowledge and points of view to shape and advance rare diseases research through foundational, diagnostics, therapeutics and policy development. The event will be held on 8-9 February 2017 in Paris, France.

More information


28 November 2016

Launch of the ICPerMed: Accelerating a personalised medicine approach for citizens

International Consortium for Personalised Medicine (ICPerMed) will support the implementation of personalised medicine and set out a policy framework covering all steps of the innovation cycle from research and innovation through to the uptake of personalised medicine in healthcare. It will address the following Commission priorities: boosting jobs, growth and investment, a connected digital market, and a stronger global actor.

More information


25 November 2016

Get involved in the next H2020 Health proposals!

Health NCP Net (HNN2.0) and Enterprise Europe Network (EEN) are organizing the next Decentralized Health Brokerage event in Zagreb (Croatia), on 19 January 2017. Registrations are open until 16 December 2016.

More information


22 November 2016

European Parliament Workshop: "Understanding the Human Brain - A new era of big neuroscience"

The Science and Technology Options Assessment is organising a workshop in Brussels where key leading representatives of three large-scale brain research initiatives from Europe, the United States and Japan will present an overview of their status, achievements, opportunities for cooperation, and future plans. The workshop will be webstreamed on 29 November 2016 from 14h30 to 17h00.

More Information


18 November 2016

The European Commission announces shortlist for the €1m Better Use of Antibiotics Horizon Prize

Today, on European Antibiotic Awareness Day, the European Commission announced the shortlisted candidates for the €1m Better Use of Antibiotics Horizon Prize – ImmunoPoC, Minicare HNL and PulmoCheck – for their ideas on developing and/or bringing-to-market a test to quickly identify whether a patient can be treated safely without antibiotics.

More Information


17 November 2016

International Human Epigenome Consortium celebrates major coordinated paper release

One of the great mysteries in biology is how the many different cell types that make up our bodies are derived from a single cell and from one DNA sequence, or genome. A collection of 41 coordinated papers now published by scientists from across the International Human Epigenome Consortium sheds light on these processes, taking global research in the field of epigenomics a major step forward. EU–funded project BLUEPRINT is a part of the Consortium and reunited 42 leading European universities, research institutes and industry entrepreneurs. As many as 26 of these coordinated papers were contributed by the EUR 30 mil project.

More Information


15 November 2016

The European Commission launches a public consultation on the Paediatric Regulation

The European Commission has launched a public consultation to get views and feedback from stakeholders, to support the Commission in drafting its second report on the Paediatric Regulation after nearly ten years of implementation. The consultation is open until 20 February 2017.

More Information


11 November 2016

Innovative funding for SMEs in Europe – BIO-Europe 2016

Photo from the Event
From left to right: Pierre Meulien, Shiva Dustdar, Cornelius Schmaltz, Ralf Schmidt

The Directorate General for Research and Innovation, European Commission, welcomed the Innovative Medicines Initiative (IMI), the European Investment Bank and, Biovotec, a successful project under the SME Instrument, at a session on SME funding in BIO-Europe 2016. The event is Europe's largest partnering conference serving the global biotechnology industry. Being present, we are able to give an overview of the SME Instrument and introduced other Horizon 2020 SME–oriented facilities, such as InnovFin, the EU Finance for Innovators as well as IMI future opportunities.

Presentations


26 October 2016

The European Commission has published the review of its Action Plan against the rising threats from antimicrobial resistance

This evaluation assesses the impact of the AMR Action Plan which covers the period 2011-2016. Specifically, the evaluation assesses whether the 12 actions contained in the Action Plan were relevant to address the problems identified, and if these actions were effective, efficient, coherent with other EU policies in combatting AMR and whether added value was provided by EU action.

More information


25 October 2016

Registrations are open for the launch event of the European Human Biomonitoring Initiative

The European Human Biomonitoring Initiative (HBM4EU) is a joint effort of 26 countries and the European Commission, co-funded by Horizon 2020. HBM4EU will thereby provide better evidence of the actual exposure of citizens to chemicals and the possible health effects to support policy making.

More information


24 October 2016

The Directorate-General for Research and Innovation releases the Personalised Medicine Conference Report

The report addresses the broader policy perspective and challenges by showcasing both integrated healthcare models in Member States and business approaches which involve patients more directly in their healthcare. The Personalised Medicine Conference 2016 took place in Brussels (1-2 June 2016) and attracted 600 participants on site and over 2.000 online.

More information


21 October 2016

European Union invests €45 million into research to combat the Zika disease

The EU is investing €45 million in research to combat the outbreak of the Zika virus disease and other emerging infections transmitted by mosquitoes. The significant funding from Horizon 2020, the EU's research and innovation programme, will support research on treatments, diagnostics and vaccines, as well as better risk assessment for Zika.

More information


14 October 2016

EU-funded project TRANSCAN-2 will launch the Joint Transnational Call for research proposals in December 2016

Interested researchers and/or research teams are advised to prepare and make the necessary contacts and arrangements towards preparing applications. The topic of the call will be: “Minimally and non-invasive methods for early detection and/or progression of cancer”.

More information


5 October 2016

EU-funded projects met to share latest results on cardiovascular research

With a total EU contribution of approximatively EUR 18 m throughout their lifetime, ongoing projects CarTarDis, CVgenes@target and TransCard gathered to share their latest results on cardiovascular research. This open sharing of technologies and most recent breakthroughs leads to optimal dissemination of latest developments supported by the EU and thus aids the increase of output from these research projects in a very relevant disease area.

More information


3 October 2016

EDCTP appoints High Representatives for Europe and Africa

The High Representatives will act as goodwill ambassadors for EDCTP in order to increase the visibility of the programme and promote partnerships with other EDCTP stakeholders in the fight against poverty-related and neglected diseases in Africa, Europe and globally.

More information


30 September 2016

PRIME – Paving the way for promising medicines for patients

PRIME is a scheme launched by the European Medicines Agency to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.

More information


29 September 2016

EU SME Cellectis wins 2016 Most Innovative European Biotech SME Award for Healthcare

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells won EuropaBio’s 2016 Most Innovative European Biotech SME Award for the healthcare category. The Awards program represents a unique annual initiative that recognizes innovative biotech small-and medium-sized enterprises (SMEs) in Europe and the crucial role that they play in answering some of society’s greatest challenges through biotechnology. Cellectis was involved as a participant in 2 EU-funded health projects under the Seventh Framework Programme for Researchers, namely ATECT (Advanced T-cell Engineered for Cancer Therapy) and SCR&TOX (Stem Cells for Relevant Efficient Extended and Normalized Toxicology).

More information


28 September 2016

GACD funds innovative research into prevention and management of lung diseases

Members of the Global Alliance for Chronic Diseases are funding more than thirteen international research projects into the prevention and management of chronic lung diseases. The research is to take place in more than 30 countries across the globe and represent over USD 55 million of research funding over 3-5 years with a focus on implementation and intervention research in low-and middle-income countries, vulnerable populations in high‐income countries and aboriginal communities.

More information


26 September 2016

EU-US collaboration to boost medicine development for rare diseases

The European Medicines Agency and the United States Food and Drug Administration have set up a new ‘cluster’ on rare diseases to share experiences and best practices on each other’s regulatory approach to the development of medicines for these diseases. The cluster will provide a forum for confidential exchange of draft documents, policies under development, and more detailed information supporting the scientific basis for decision making on medicine development.

More information


21 September 2016

The Eighth EDCTP Forum, 6-9 November 2016, Zambia

The biennial EDCTP Forum is one of the most prominent conferences on HIV/AIDS, tuberculosis, malaria and other neglected infectious diseases prevalent in Africa and is expected to gather some 600 delegates. The Eighth Forum is organised by EDCTP in partnership with the Ministry of Health of the Republic of Zambia. EDCTP will award four international prizes dedicated to the promotion of scientific research, improved health and Africa-European collaboration.

More information


9 September 2016

Independent Advisory Panel on characterising flavours in tobacco products - Call for expression of interest

The European Commission is looking for experts in sensory analysis, chemical analysis and statistics to join a newly established independent advisory panel assisting Member States and the Commission in determining whether tobacco products have a characterising flavour.

More information


6 September 2016

Innovative Medicines Initiative publishes Call 10 topics

The world's biggest public-private partnership in the life sciences publishes topics for Call 10, which is scheduled for launch in autumn 2016. All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board.

More information


5 September 2016

International epigenetics EU–funded project delivers beyond expectation

Researchers from the BLUEPRINT project join their international colleagues this week at the 2016 International Human Epigenome Consortium (IHEC) conference in Brussels to report the latest results in understanding blood cell development and blood disease. BLUEPRINT received €30 million from the European Union to decipher the role of epigenetics in normal and diseased blood cells. Epigenetic effects alter the activity of genes without altering the DNA code, and play an important role in development and disease.

More information


26 August 2016

Save the date: Third conference of the International Rare Diseases Research Consortium (IRDiRC)

8-9 February, 2017 at the conference center of Université Pierre et Marie Curie in Jussieu, Paris, France.

More information


26 August 2016

EU invests over €1bn to fight antimicrobial resistance

Deaths from drug-resistant microbes could be 10m a year by 2050. The European Union (EU) has been committed to combating AMR since 1999, and has continued to prioritise research on AMR in its Horizon 2020 research programme. As part of this commitment, the EU has spent more than €1 billion on AMR research.

More information


18 August 2016

EDCTP publishes the list of calls

Having its main focus on Sub-Saharan Africa, the European & Developing Countries Clinical Trials Partnership puts together a list of calls for proposals which vary from vaccines for poverty-related diseases and strategic actions supporting large-scale clinical trials to a wide range of fellowships meant to support the researchers of tomorrow.

More information

10 August 2016

Health National Contact Points Meeting – Conclusions and testimonials

Directorate Health, DG Research and Innovation, European Commission, organised together with the EU-funded projects HNN 2.0 and Fit for Health the Health NCP Meeting. The purpose of the event was to better advise the representatives of the Member States (NCPs) on how to respond to the Horizon 2020 applicants as regards to finding the right project partners for the upcoming 2017 Health calls, submitting proposals and also budget wise.

More information

25 July 2016

The European Commission publishes the Work Programme 2016–2017 in the area of Health, demographic change and well-being

TheThe EC confirmed the calls and other actions of the second year of the two-year work programmes setting out funding opportunities for 2017. Horizon 2020 Work Programme will contribute to the Jobs, Growth and Investment Package helping to strengthen Europe’s global competitiveness through innovation to create new and sustainable jobs and promote growth. Horizon 2020 Societal Challenge 1 focuses on personalised health and care and benefits from a budget of EUR 331.76 million.

More information

20 July 2016

The European Commission participates at the 21st International AIDS Conference, Durban, South Africa

The European Commission together with the European and Developing Countries Clinical Trial partnership is hosting the satellite symposium " Every Mother, Every Child: Closing the Gaps in HIV management" within the AIDS2016 in Durban. During the symposium main experts on maternal, child and adolescent health will highlight prominent advances in the field while also presenting and discussing the major research bottlenecks. Accomplishments of recent EU and EDCTP-funded projects and the future plans in this area will also be presented.

More information

15 July 2016

EU-funded initiative COMET organises meeting on preparation of health research outcomes

The COMET Initiative is working to improve the quality of health care by facilitating the preparation of core outcome sets which could be used in research, including randomised trials and systematic reviews, in a specific topic area. The sixth COMET meeting will be held in Amsterdam on 10-11 November 2016. The programme will provide opportunities for individuals interested in the development and application of core outcome sets across different areas of health and social care to share ideas and learn more.

More information

28 June 2016

Health Information Day – Registration closed

The Health Information Day on Horizon 2020 Societal challenge 1 (SC1) calls for 2017 will take place on 8 July in Brussels. SC1 updated Work Programme 2017 offers calls for proposals with an overall budget of about € 400 million.

More information

8 June 2016

Advisory Group publishes report

The Advisory Group report on the Horizon 2020 Societal Challenge 1 "Health, Demographic Change and Well-being" for period 2018-2020 is now available.

More information

24 May 2016

Personalised Medicine Conference 2016 – last chance to register

Europe is a leader in personalised medicine, an interdisciplinary field which will drive the health research and innovation agenda for years to come in view to improve healthcare. The conference will introduce a new collaboration among health research funding and policy making organisations called the International Consortium for Personalised Medicine (IC PerMed). Please register by 26 May, midnight.

More information

28 April 2016

Launch of the Horizon Birth Day Prize

The Birth Day prize will be awarded for a solution that improves care and reduces death and illness of mothers and babies during delivery in a health facility around the world.

More information

25 April 2016

Zika International Meeting Paris

The speed and extent of this outbreak, which the WHO declared a Public Health Emergency of International Concern, requires open collaborations between researchers, the public health community and the public. Direction General Research, European Commission, attends this 2-day meeting on 25-26 April 2016. The purpose of the meeting is to bring together scientists and public health professionals around the world working on Zika

More information

24 April 2016

The European Commission hosts the Global Health Policy Forum on Access to Medicines

On 26 April 2016, the European Commission will organise the second Global Health Policy Forum in 2016. The main target includes access to medicines with a particular focus on WHO essential medicines and the impact of voluntary licensing on access to medicines. The European Commission organises the Global Health Policy Forum four times a year to meet and exchange information with representatives from a variety of different institutions, including international bodies such as the WHO and UN, civil society organisations like Médecins Sans Frontières, private sector companies and academic institutions. The first Global Health Policy Forum in 2016 focused on health and migration.

More information

19 April 2016

Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Regimen in JAMA

We are delighted to see such positive results produced by a consortium supported with grants from the Ebola+ programme. These and the many other Ebola studies underway with the European Commission and IMI support show that cooperation research and public-private partnerships can be formed with great speed to develop innovative solutions for today’s most pressing global health threats. Only by joining forces as an international community can we prevent, control, and end pandemics.” said Ruxandra Draghia-Akli, Director, Health Directorate, European Commission.

More information

1 April 2016

Health Information Day

SAVE THE DATE! The Health Information Day on Horizon 2020 Societal challenge 1 calls for 2017 will take place on 8 July in Brussels. The event targets a wide range of participants, mostly applicants for the H2020 research programme

More information

15 March 2016

EU supports Zika research with €10 million

The European Commission is today releasing €10 million for research on the Zika virus, currently affecting large parts of Latin America.

More information

14 March 2016

EU needs to step up its research and innovation performance, report finds

Publication of the RTD Report: 'Science, Research and Innovation performance of the EU 2016: a contribution to the open innovation, open science, open to the world agenda'. The report makes the connection between investing in Research & Innovation and economic growth.

More information

29 February 2016

Rare diseases day

The last day of February every year is Rare Disease Day. Read the joint blog post of Commissioner Carlos Moedas (Research and Innovation) and Commissioner Vytenis Andriukaitis (Health and Food Safety) , where they outline what the EU is doing in the area.

More information

16 February 2016

EU-funded project EuroFIT: kicking unhealthy lifestyles into touch

Logo

The project developed the programme to encourage overweight and obese men to improve their diets, and become more active and less sedentary. The researchers hope the trial will provide a model that could be replicated by other football clubs across Europe – leading to fitter fans and healthier lifestyles.

More information

10 February 2016

Zika virus: pre-publication of the draft topic

Zika virus disease is a mosquito-borne viral disease caused by the Zika virus (ZIKV) that has recently been spreading through the South Pacific and Latin America. In November 2015, preliminary evidence emerged that ZIKV may be associated with an observed increase in neurological complications (Guillain-Barré syndrome) in adults and severe congenital brain malformations in newborns born to mothers infected during pregnancy...
Read more.

5 February 2016

Launch of EU-CELAC Joint Initiative on Health Research and Innovation

15 March 2016, Brussels

EU-LAC Health has been paving the way for the EU-CELAC Joint Initiative on Health Research and Innovation (JIRI-Health) towards the EU-CELAC Common Research Area.

JIRI-Health is envisioned as a joint initiative between European Union (EU) and Latin America and the Caribbean (LAC) countries with the objective of developing bi-regional joint programming in health research and innovation by using funding instruments already existing to fund projects and activities according to aligned topics jointly agreed between the EU and LAC countries, upon flexible and variable geometry.

More information

2 February 2016

New section on Zika research

Bookmark this new page to follow the work being done on the Zika virus.

1 February 2016

European Commission urges support for urgent Zika research

€10 million were urgently mobilised for needed research on the Zika virus in response to the upsurge in cases of severe congenital brain malformations across Latin America and their suspected link to Zika virus infections. Horizon 2020 has additionally some relevant calls for research proposals that can help in the fight against Zika. One is a €40 million call for research on vaccine development for malaria and neglected infectious diseases, which includes the Zika virus.

More information

28 January 2016

InnovFin provides €20 million to help develop treatments for hepatitis, cancer and tuberculosis

The development of innovative treatments for infectious diseases such as hepatitis B and tuberculosis as well as for human papillomavirus-induced cancer will get a boost thanks to a new €20 million loan to French biopharmaceutical company Transgene SA, provided by the InnovFin Infectious Diseases facility. The deal is the second one signed under InnovFin ID, a debt instrument developed under the EU's research and innovation funding programme Horizon 2020.

More information

26 January 2016

Writing successful proposals including Socio-economic Sciences and Humanities aspects

Webinar, 2 February 2016

On 2 February 2016, the Health NCP Network in partnership with Net4Society will organise a webinar on Socio-economic Sciences and Humanities (SSH) in the context of Horizon 2020, the EU framework programme for research and innovation. This activity will allow you to understand what the SSH integration means and how to integrate the SSH disciplines within your project proposals. The deadline for registration is 28.01.2016.

More information

25 January 2016

The UK and Bill Gates announce €4 Billion to eradicate Malaria

Chancellor George Osborne and Bill Gates have announced €4 billion in funding over the next five years for research and to support efforts to eliminate the mosquito-borne disease.

More information

22 January 2016

Understanding and Tackling the Migration Challenge: The Role of Research

Conference, 4-5 February 2016, Brussels

The European Commission's Directorate-General for Research and Innovation is holding a two-day conference to explore and demonstrate how European research can support policy makers in designing effective and sustainable migration policies.

To this end, past and current research on migration - including research on integration, circular migration, migration and development, data and statistical modelling - will be presented and debated from a policy perspective.

More information

12 January 2016

H2020 European Health Brokerage Event – Paris 2016

On 13 January 2016, the Health NCP Net 2.0, the Life Sciences cluster MEDICEN Paris Region and the Chamber of Commerce and Industry Paris Ile-de-France, member of the Enterprise Europe Network are organising the next H2020 European Health Brokerage Event in Paris.

More information

7 January 2016

EU-funded project Ebola-Tx: trial of convalescent plasma to treat Ebola is safe but more data is needed to determine benefits

Results of the European Union funded Ebola-Tx trial on the effect of treating Ebola patients with plasma from Ebola survivors appeared today in the New England Journal of Medicine. The trial showed that treatment with convalescent plasma during an Ebola virus disease outbreak is feasible, safe to use and acceptable to donors, patients and health workers. "Even though the treatment studied proved to be ineffective in treating Ebola, we strongly encourage specialised journals to keep publishing this type of findings as an explicit example of health research for the benefit of patients worldwide." said Ruxandra Draghia-Akli, Director, Health Directorate, European Commission.

More information

18 December 2015

IMI has launched its 7th and 8th calls for proposals

The Innovative Medicines Initiative (IMI) is launching two Calls for proposals that will advance medicines development in critical areas such as Ebola, childhood cancers, neurological disorders, and eye disease. The Calls will also add to IMI’s growing programme on Big Data for Better Outcomes.

More information

15 December 2015

Commissioner Moedas' visit to the Health Directorate

The Commissioner congratulated the staff for its hard working, characterising the Health Directorate as being one of the lead voices in Direction General for Research and Innovation. He further emphasized that health is a landmark topic in European discussions and that we can achieve much more working in partnerships on a global scale.

11 December 2015

MCD EU-funded project company In2Care got $ 10.2 m to move to commercialisation

In collaboration with partners in Europe and Africa, researchers at Penn State have received a five-year, $10.2-million grant from the Bill & Melinda Gates Foundation to run a Phase III trial with eave tubes in order to prevent the transmission of malaria and to move towards commercialisation.

10 December 2015

EDCTP receives Science Diplomacy Award at South African Science Forum

EDCTP is recognised for its work in building capacities to undertake clinical trials in Africa for the fight against both the major and neglected infectious diseases. The award was given by the Hon. Naledi Pandor, South African Minister for Science and Technology and received by Dr Thomas Nyirenda, Manager of South-South Networking, on behalf of EDCTP.

8 December 2015

A focus on patients - The Innovative Medicines Initiative in action

Patients are at the heart of the EU’s Innovative Medicines Initiative (IMI) that seeks to speed up the development of more effective and safer medicines. IMI plays a leading role in the EU’s efforts to remove barriers to the discovery of new treatments.

7 December 2015

TRANSCAN-2 launches the second Joint Transnational Call for Proposals

Submission deadline for pre-proposals: 5 February 2016

The ERA-NET: Aligning national/regional translational cancer research programmes and activities TRANSCAN-2 is the continuation of the ERA-NET on Translational Cancer Research (TRANSCAN) and has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The topic of the call is: “Immunology and immunotherapy of cancer: strengthening the translational aspects”
Submission deadline for pre-proposals: 5 February 2016 at 16:00 (CET) .

1 December 2015

AIDS stigma will spread the disease
an interview with Prof. Nathan Clumeck

The stigma associated with AIDS and homophobia has made the pandemic even more destructive as in many countries it drives people away from modern treatment that could let them live a normal life. HIV has become a chronic disease that can be treated efficiently, but that implies the patient complies with medication and therapy.

30 November 2015

World AIDS Day 2015: Joint Statement by HR/VP Mogherini and Commissioners Andriukaitis, Mimica and Moedas

Funding research and innovation, supporting the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), funding specific projects and joint actions with Member States and stakeholders on testing, prevention and co-infections, under the EU Health Programme, supporting developing countries in strengthening their health systems are among the concrete measures taken by the EU in its fight against HIV/AIDS.

25 November 2015

Irish SME to receive € 4.2 million under Horizon 2020 SME Instrument – Phase 2

PMD Solutions is one of 38 innovative SMEs across Europe selected under this round for funding. The funding will be directed towards developing a new respiratory monitoring device to improve patient outcomes.

24 November 2015

New EDCTP-TDR Clinical Research and Development Fellowships awarded

A total of 18 product development clinicians from 9 low-and middle-income countries have been awarded clinical research and development fellowships. These fellows are supported by TDR, the Special Programme for Research and Training in Tropical Diseases, and will be placed with 10 host institutions by early 2016. The EDCTP-supported fellowships will be announced early next year.

23 November 2015

Bibliometric analysis of the scientific papers confirm high quality vaccine research

High quality vaccine research funded by the EUR 30 million FP7 High Impact Project ADITEC is confirmed by the bibliometric analysis of the scientific papers produced by the project. The investments of the European Commission in the project have already had and will continue to have a substantial impact on the future of the vaccinology research in Europe and beyond, as well as on the development of new immunization technologies.

20 November 2015

Final FP7 evaluation report handed to Commissioner Moedas

The 7th EU Research Framework Program has supported more than 30,000 universities, research institutions, companies and NGOs with a volume of approximately 55 billion Euros between 2007 and 2013. Valuable suggestions were made and also recommendations for Horizon 2020.

20 November 2015

The European Medicines Authority published a positive scientific opinion on 3-day treatment for uncomplicated malaria

The new label (Pyramax®) allows it to be used for treating multiple episodes of malaria in the same person, in any malaria-endemic country. Even more excitingly, the child-friendly fixed-dose ACT Pyramax® Granules is the first paediatric antimalarial to be approved by the European Medicines Authority.

19 November 2015

Success Story – SME Instrument Phase 2 company goes Nasdaq

In March 2015 Immunovia was granted a two-year € 4.2 million funding from Horizon 2020. The EU grant application was approved to support the clinical validation of Immunovia’s biomarker signature, IMMray™ PanCan-d, the first blood-based test for early diagnosis of pancreatic cancer.

19 November 2015

South African Minister of Science and Technology puts forwards ETCTP as a beneficial global partnership

Developing countries today are at the forefront of global scientific discovery, as highlighted for example by the pioneering work undertaken in South Africa in areas such as microbicides to prevent HIV/Aids, as well as drug and vaccine development for malaria and tuberculosis. This is shown by the full participation, including as funding parties and equal partners, by several African countries in the European Developing Countries Clinical Trials Partnership.

17 November 2015

Diabetes Literacy EU-funded project releases video

The Diabetes Literacy Consortium hosted its final event “Diabetes Literacy: Strengthening Diabetes Self-Management for all in Europe”. The animation provides a short overview of the project's work, and the messages discussed at the conference.

16 November 2015

European Antibiotic Awareness Day

The European Centre for Disease Prevention and Control organised a conference on the occasion of the EAAD. Ruxandra Draghia-Akli, Director, Health Directorate, DG RTD, had a comprehensive presentation on Antimicrobial Resistance from acting local to going global. Getting a personalised treatment was also emphasised. SME-led EU funded projects like Chips4Life and Routine have developed tools towards identifying the right treatment for one's specific needs.

6 November 2015

Sure Chill announced as "the most innovative new cold chain technology of the year"

Sure Chill, which received an honourable mention for the inaugural European Commission Vaccine Prize, was named as the award winner at the prestigious Global Cold Chain Forum in Boston, USA. The award, which received entries from around the world, was judged by a panel of industry leading experts from Merck, Novartis, US Pharmacopeia and others.

5 November 2015

Health Directorate participation within BIO-Europe 2015, 2-4 November 2015

Officials within the Health Directorate, DG RTD, were among the panellists involved in the programme of one the most important events for the biotech industry in Europe. The 2 sessions were: Alternative Financing (coordinated by the European Commission) and Global vaccine outlook.

30 October 2015

Type 1 diabetes research: taking stock and maximising collaboration

The European Commission and the JDRF (formerly Juvenile Diabetes Research Foundation) jointly organised a workshop on type 1 diabetes with the ultimate goal of defining the state-of-art in the field, identifying gaps, and brainstorming about the possibilities offered by personalised medicine approaches in this area.

29 October 2015

Launch of EU-CELAC Joint Initiative on Health Research and Innovation

EU-LAC Health paving the way for the EU-CELAC Joint Initiative on Health Research and Innovation (JIRI-Health) towards the EU-CELAC Common Research Area.
The Event will take place on 23 November 2015 in Brussels, Belgium.

25 August 2015

Together for the Next Generation, Research and Innovation for Maternal and Newborn Health - 8 December

Research has a crucial role to play in improving the health of mothers and children, this being one of the priorities of the European Commission. Global coordination is essential to achieving health and wellbeing, particularly at this time of transition from MDGs to SDGs. Organised by the Directorate-General for Research and Innovation, the Research and Innovation for Maternal and Newborn Health Conference will take place on the 8 December in Brussels.

20 August 2015

GACD funds landmark research into prevention and treatment of type 2 diabetes

Members of the Global Alliance for Chronic Diseases will fund sixteen research projects to prevent and treat type 2 diabetes with over USD 30 million. The research is to take place in twenty-five low-and middle-income centres across the globe. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: "Fighting a global problem requires a global effort and the European Commission is proud to contribute to the coordinated GACD initiative. Three research projects funded through Horizon 2020 and worth €10 million will help better control, manage and prevent the disease."

14 July 2015

Dr Michael Makanga designated as next EDCTP Executive Director

'During the last General Assembly of the European & Developing Countries Clinical Trials Partnership (EDCTP), Dr Michael Makanga was selected to succeed Professor Charles Mgone as Executive Director. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: 'EDCTP is a flagship initiative under Horizon 2020 whose ambitious goals require commitment and leadership. Michael Makanga's invaluable experience will help EDCTP deliver and succeed on its objectives.'

13 July 2015

First loan under InnovFin Infectious Diseases provides €10 million to improve HIV testing

The European Investment Bank provided today a €10 million loan to Cavidi AB for the development of an automated version of its existing manual device for HIV viral load testing. This low cost testing device is proven to work in simplified less sophisticated laboratories thus allowing to perform, in a practical and affordable manner, regular assessment of HIV positive patients also in low-and middle-income countries.

10 July 2015

EU response to the Ebola outbreak in West Africa

The European Commission has promptly and strongly supported urgent Ebola research on potential treatments, vaccines and diagnostic tests with almost €140 million from Horizon 2020, the EU's research and innovation funding programme. Additionally, the European Commission and the European pharmaceutical industry are funding eight research projects on the development of vaccines and rapid diagnostics tests, which are key to overcoming the current Ebola crisis. These projects are run under the new 'Ebola+' programme of the Innovative Medicines Initiative (IMI) and funded with a total of €215 million, €114 million of which come from Horizon 2020. The factsheet was published on the occasion of the International Ebola Recovery Conference during which Commissioner Christos Stylianides announced €450 million to support the recovery of the three countries most affected by Ebola - Guinea, Sierra Leone and Liberia.

 

 

Upcoming Events

7-9 August 2017, Paris, France - 6th World Congress on Pharmacology

13-17 August 2017, Basel, Switzerland - WCS 2017 - World Congress of Surgery by ISS/SIC

14-15 August 2017, Edinburgh, Scotland - 6th International Conference on Pediatric Nursing and Healthcare

More Events

Read about our Success Stories

Social Corner

twitter logo

Follow us on Twitter


Facebook logo Find us on Facebook on the EU Science & Innovation page page